![Lauren Rachel Lees](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lauren Rachel Lees
Nessuna posizione attualmente
Storia della carriera di Lauren Rachel Lees
Precedenti posizioni note di Lauren Rachel Lees
Società | Posizione | Inizio | Fine |
---|---|---|---|
DEEPMATTER GROUP PLC | Comptroller/Controller/Auditor | 01/10/2018 | 28/06/2019 |
Direttore/Membro del Consiglio | 01/10/2018 | 01/11/2020 | |
Direttore Finanziario/CFO | 28/06/2019 | 01/11/2020 | |
Segretario Aziendale | 28/06/2019 | 01/11/2020 | |
Sartorius Stedim BioOutsource Ltd.
![]() Sartorius Stedim BioOutsource Ltd. Medical/Nursing ServicesHealth Services Part of Sartorius AG, Sartorius Stedim BioOutsource Ltd. is a British company that provides contract testing services of biologic drugs and vaccines. The company is based in Glasgow, UK. The company was founded in 2007. The CEO is Hugo de Wit. Sartorius Stedim BioOutsource was acquired by Sartorius Stedim Biotech SA on April 17, 2015. | Comptroller/Controller/Auditor | - | - |
Statistiche
Distribuzione geografica
Regno Unito | 3 |
Posizioni
Comptroller/Controller/Auditor | 2 |
Director/Board Member | 1 |
Director of Finance/CFO | 1 |
Settori
Technology Services | 2 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
DeepMatter Group Plc
![]() DeepMatter Group Plc Packaged SoftwareTechnology Services DeepMatter Group Plc is engaged in the development of a number of projects targeting new chemicals, materials, formulations, and pharmaceuticals in commercial areas. It operates through the following segments: DeepMatter and InfoChem. The DeepMatter segment owns, develops and is in the early stage of exploiting intellectual property, software, hardware and data analysis capabilities combined as a visionary, disruptive platform called DigitalGlassware, enabling step changes in productivity and discovery for scientists in the pharma and life science sectors. The InfoChem segment develops and commercialises cheminformatics software to handle, store and retrieve chemical structures and reactions for application in pharma, life sciences, and scientific publications. The company was founded by Jon-Paul Griffiths and Mark G. Moloney on June 13, 2006 and is headquartered in Glasgow, the United Kingdom. | Technology Services |
Sartorius Stedim BioOutsource Ltd.
![]() Sartorius Stedim BioOutsource Ltd. Medical/Nursing ServicesHealth Services Part of Sartorius AG, Sartorius Stedim BioOutsource Ltd. is a British company that provides contract testing services of biologic drugs and vaccines. The company is based in Glasgow, UK. The company was founded in 2007. The CEO is Hugo de Wit. Sartorius Stedim BioOutsource was acquired by Sartorius Stedim Biotech SA on April 17, 2015. | Health Services |
- Borsa valori
- Insiders
- Lauren Rachel Lees
- Esperienza